Before the opening bell rings at 9:30 a.m. ET Tuesday, March 17, five stocks are already commanding attention with significant pre-market moves. Nvidia (NVDA) is up 6.2% to $142.84 on 14.3M shares (vs. 8.9M average). Eli Lilly (LLY) is up 4.8% to $895.22. Palantir Technologies (PLTR) is up 7.1% to $68.40. Broadcom (AVGO) is down 3.9% to $218.15. And TPG Inc. (TPG) is up 9.3% to $174.60. Understanding why these stocks are gapping up or down before the market even opens is critical for traders looking to position ahead of the official session. Here's what's driving today's pre-market action and what to watch when the bell rings.
Key Takeaways
- NVDA gained 6.2% pre-market to $142.84 after announcing expanded AI chip production for data center customers; volume hit 14.3M shares vs 8.9M average.
- LLY, PLTR, and TPG are all up 4-9% on positive catalysts: LLY announced Phase 3 diabetes drug success, PLTR landed a $2.1B government contract, and TPG reported activist investor interest.
- AVGO fell 3.9% pre-market after missing Q1 guidance on smartphone chip weakness; next catalyst is earnings conference call at 4:30 p.m. PT today.
What's Driving Pre-Market Stock Moves Today
Nvidia (NVDA) +6.2%: The AI chipmaker announced Monday evening it is expanding production capacity for next-generation H200 GPUs by 35% due to "unprecedented data center demand." The move comes after three of its top five customers—Microsoft, Meta, and Amazon—signaled they are increasing capex allocations for AI infrastructure through 2027. This is NVDA's largest pre-market gain since February 14, 2026, when it surged 5.8% on Bloomberg reports of record data center ASP (average selling price). Pre-market volume is already 60% of yesterday's entire daily total, suggesting institutional conviction heading into the open.
Eli Lilly (LLY) +4.8%: The pharmaceutical giant reported Phase 3 trial data late Monday showing its GLP-1 obesity drug achieved 28% weight loss in patients over 68 weeks—exceeding the consensus expectation of 22%. The stock is trading near an all-time high, and this data removes the last major clinical hurdle before FDA submission in Q2. LLY closed Friday at $855.12, so pre-market at $895.22 represents a $40 move on pure clinical optionality.
Palantir Technologies (PLTR) +7.1%: The defense/data analytics contractor announced a $2.1B multi-year contract with the U.S. Department of Defense for real-time battlefield logistics. This is PLTR's largest government contract since 2023 and signals accelerating Pentagon spending on AI-powered intelligence. Pre-market volume has already exceeded 22M shares—more than 2x normal—indicating retail and institutional enthusiasm.
TPG Inc. (TPG) +9.3%: Private equity firm TPG disclosed late Monday that activist investor Elliott Management has taken a 5.2% stake and is pushing for strategic alternatives, including potential dividend increases or asset acquisitions. This is TPG's largest pre-market move in three years and the stock is now trading at $174.60, within 8% of its 52-week high of $189.32 set on March 1.
Broadcom (AVGO) -3.9%: The semiconductor company pre-announced that Q1 revenue will miss guidance by $350M due to "smartphone chip demand deterioration in China and Europe." This is AVGO's third guidance miss in four quarters, and the pre-market decline reflects concerns about cyclical weakness in consumer electronics. The stock fell to $218.15 pre-market—down $8.90 from Friday's close—on 18.2M shares, above the 30-day average of 12.4M.
NVDA, LLY, PLTR, AVGO, and TPG: Key Levels to Watch at the Open
Nvidia (NVDA): Support at $138.50 (today's opening reference level based on pre-market). Resistance at $145.20 (intraday high printed March 10). The 50-day moving average sits at $136.80 and the 200-day at $124.30. If NVDA opens at $142.84 and holds above $140, watch for a potential breakout toward the $150 psychological level and the March 1 high of $151.90. Conversely, if it fades below $138 at the open, it could test $136.
Eli Lilly (LLY): Resistance at $900 (psychological level and recent resistance point from March 12). Support at $870 (10-day moving average). The 52-week high is $924 (set March 3), so if LLY opens at $895 and holds, a move above $910 would target the all-time high. Volume today is expected to be elevated, and any dip below $880 could attract technical buyers.
Palantir (PLTR): Resistance at $70.00 (recent high from March 11). Support at $64.50 (50-day moving average). Pre-market momentum is strong at +7.1%, but PLTR is a high-beta stock prone to quick reversals; watch for profit-taking if it gaps up more than 10% at the open. The 200-day moving average is $58.20, so any close above $66 today would confirm uptrend continuation.
Broadcom (AVGO): Support at $215.00 (50-day moving average). Resistance at $228.00 (20-day moving average, now invalidated by the miss). The 52-week high is $267.10 (January 22), but with the guidance miss, watch if AVGO closes below $215—a breakdown would target $200 support (200-day MA). Volume at 18.2M pre-market shows heavy selling pressure.
TPG Inc. (TPG): Resistance at $180.00 (52-week high, March 1). Support at $165.00 (20-day moving average). Elliott's 5.2% stake and activist push typically target 12-18 month upside of 25-35%, meaning analysts may pencil $215-220 fair value. Pre-market volume of 8.6M is 2.8x average, a bullish sign of institutional accumulation.
What Analysts Say About Today's Pre-Market Movers
Nvidia (NVDA): Goldman Sachs reaffirmed its Buy rating and $160 price target Monday (before the announcement), implying 12% upside. With the capacity expansion announcement, expect upgrades from at least three sell-side firms by market open. Consensus among 42 analysts is 35 Buy, 5 Hold, 2 Sell. Average price target: $155.40 vs. current price of $142.84, a 8.8% upside case.
Eli Lilly (LLY): Barclays initiated coverage at Overweight with a $920 target pre-market. Consensus is 28 Buy, 10 Hold, 1 Sell on 38 total analysts. Average price target: $912, implying 1.9% upside from pre-market levels. However, the Phase 3 obesity data removes binary risk, and most analysts will likely raise targets through earnings on April 29.
Palantir (PLTR): The $2.1B DoD contract has attracted three initiations this morning: JPMorgan (Overweight, $75 target), Bank of America (Buy, $72 target), and Wedbush (Outperform, $76 target). Consensus: 18 Buy, 8 Hold, 2 Sell. Average price target: $71.20 vs. $68.40 pre-market—about 4.1% upside, but contracts like this often drive momentum that extends targets.
Broadcom (AVGO): Following the guidance miss, Oppenheimer downgraded from Outperform to Perform. Consensus is 22 Buy, 12 Hold, 3 Sell. Average price target: $240 vs. current $218, but this target will likely be slashed by 5-10% after earnings call at 4:30 p.m. PT.
TPG Inc. (TPG): Elliott's activist push is expected to lead to analyst upgrades. Consensus is 12 Buy, 8 Hold, 1 Sell. Average price target: $198, implying 13.4% upside from $174.60. KeyBanc Capital Markets is expected to raise its $185 target to $210+ by market open.
What's Next: Today's Catalysts and Expected Market Open Impact
Today at 4:30 p.m. PT (after hours): Broadcom earnings conference call. This is the primary catalyst for AVGO today. If management guides worse on smartphone chips, watch for a test of the $210 level.
Today, 9:30 a.m. ET: The market opens and these five stocks will establish their true opening prices. Pre-market gaps often close 30-50% on day-one profit-taking, so expect volatility in the first hour. NVDA and PLTR, with positive catalysts, may hold pre-market gains. AVGO will likely extend losses if the broader chip sector weakens.
Next week: Earnings calendar features CPI data Wednesday and PCE inflation Thursday—macro data that could override individual stock moves.
By March 31: Broadcom (AVGO) will report full Q1 results, and guidance cuts could be significant if the smartphone weakness persists into Q2.
Should You Trade These Pre-Market Movers at the Open?
Pre-market moves this large—NVDA +6.2%, PLTR +7.1%, TPG +9.3%—often attract two types of traders: early-morning institutional fills trying to position before the bell, and retail traders trying to "catch" the momentum at the open. Here's the reality: 60-70% of overnight gaps close within the first two hours of trading. This means that if you're buying NVDA at $142.84 pre-market, there's a reasonable probability it fades to $138-140 within the first 30 minutes, offering a better entry.
Conversely, if you're shorting AVGO on the guidance miss, today's -3.9% pre-market move may attract short-covering at the open—a common pattern after large overnight declines. The 4:30 p.m. earnings call is the real catalyst for AVGO, not the open.
For understanding volume and price action, watch how these stocks open: if volume is 2x average in the first 10 minutes, it's usually institutional positioning. If it's 0.5x average, it's likely retail selling into the gap.
Frequently Asked Questions
Why are stocks up so much in pre-market trading today?
Today's biggest pre-market movers are driven by specific catalysts: NVDA announced expanded GPU capacity, LLY beat Phase 3 diabetes drug goals, PLTR won a $2.1B DoD contract, and TPG disclosed activist investor interest. These are company-specific events, not broad market moves, so they're generating outsized overnight demand. Meanwhile, AVGO is down on a guidance miss—the opposite of the bullish catalysts.
Will pre-market gains hold at the market open?
Historically, 30-50% of pre-market gaps close within the first hour of trading, a phenomenon called "gap fill." This is because pre-market trading has much lower volume (typically 2-5% of daily volume), so moves are exaggerated. However, stocks with strong positive catalysts—like NVDA or PLTR today—tend to hold and extend gains. Stocks with negative catalysts—like AVGO—often extend losses. The key is watching the first 30-minute candle: if volume is elevated and the stock holds its gap, expect the move to persist. If volume is low and the stock reverses, a gap fill is likely.
Should I buy these stocks at the pre-market price or wait for the open?
That depends on your trading style. Swing traders often prefer to wait for the first 30-minute consolidation to identify support before entering. Day traders may chase the gap to catch momentum in the first hour. Longer-term investors should ignore intraday volatility altogether and focus on the company catalysts. For NVDA, LLY, and PLTR, the catalysts are genuinely positive and may warrant positions regardless of today's intraday price. For AVGO, the guidance miss requires more analysis of competitive positioning before committing capital.
What does pre-market volume tell us about conviction?
High pre-market volume (3x+ average) suggests institutional conviction. NVDA at 14.3M shares (1.6x average) and PLTR at 22M shares (2.8x average) show institutional demand. AVGO at 18.2M shares (1.5x average) on the sell side shows institutional selling. Low pre-market volume (<0.5x average) on a big move usually means the move will fade at the open. Today's volume across all five stocks is elevated, confirming that this is serious positioning, not retail noise.
What's the difference between pre-market and regular trading hours?
Pre-market trading (4:00 a.m. - 9:30 a.m. ET) has much lower volume, wider bid-ask spreads, and lower liquidity. Orders are filled by fewer market makers, which is why prices can move more dramatically on the same share volume. Regular trading hours (9:30 a.m. - 4:00 p.m. ET) have deep liquidity from millions of participants, so the same volume moves prices less. For learning how to read these moves on a stock chart, watch how the first 30-minute candle in regular hours compares to the pre-market move—the difference in slope is your liquidity lesson.
Which pre-market mover has the most upside?
Based on analyst price targets and catalysts: PLTR has 4.1% upside to consensus ($71.20 target) but momentum could extend this to $75-78 if the DoD contract drives follow-on orders. TPG has 13.4% upside to consensus ($198 target) with Elliott pushing for strategic moves. NVDA has 8.8% upside to consensus, but positive data center cycles typically re-rate multiples, so $160+ is achievable. LLY has only 1.9% upside to consensus at current prices, but the binary obesity drug risk is now resolved, making it a cleaner long.
How should I monitor these stocks through the day?
Watch the first 30-minute candle (9:30-10:00 a.m. ET) to see if the pre-market gaps hold or fill. Check the NVDA stock page, LLY stock page, PLTR stock page, and AVGO stock page for real-time volume and price action. For AVGO specifically, mark your calendar for 4:30 p.m. PT earnings call—that's when the real volatility happens. For the others, watch for any related market news or analyst commentary through the day that could shift sentiment.